Anesiva, Inc. Names as President, Chief Executive Officer and Member of Its Board of Directors

www.biospace.com | Jun 16, 2008

SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. today announced the appointment of Michael L. Kranda as president, chief executive officer and a member of the company's board of directors, effective June 16, 2008. Mr. Kranda succeeds John P. McLaughlin, who resigned

http://www.biospace.com/news_story.aspx?StoryID=100416&full=1

Anesiva, Sagent sign distribution agreement for Zingo

www.pharmaceutical-business-review.com | Oct 12, 2007

Biopharmaceutical company Anesiva and Sagent Pharmaceuticals have entered into an agreement under which Sagent will co-promote and manage US distribution for Anesivas Zingo powder intradermal needle-free injection for pain reduction.

http://www.pharmaceutical-business-review.com/article_news.asp?guid=A492A7CE-51A6-4C86-843C-5CDA41378CDA

Manufacturing Business Technology CommunityNewsLN 47312 7161

www.mbtmag.com

Manufacturing Business Technology is about the use of information technology and enterprise applications in plant operations, enterprise planning, and supply chain

http://www.mbtmag.com/CommunityNewsLN/47312.html?starting=7161

Anesiva, Inc. and Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program; to Receive Upfront License Fee, Additional Payments And Milestones Up To $114 Million

www.biospace.com | Jun 5, 2008

SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV - News) today announced that it has out-licensed all worldwide rights to its NF-kappa B Decoy (NF-kB Decoy) program, which includes the clinical drug candidate Avrina(TM), to Transcription Factor Therapeutics,

http://www.biospace.com/news_story.aspx?StoryID=99151&full=1

Anesiva, Inc.

News Resources Jobs Companies Diseases Events Experts News Breaking News By Subject Archive BioBuzz Newsletters Biospace Forums Hotbed Communities Bio NC™ BioCapital™ BioForest™ new BioMidwest™ BioGarden™ (NJ) Biotech Bay™ Biotech Beach™ Genetown™ Pharm Country™ Southern Pharm™ new Career Center

http://www.biospace.net/company_profile.aspx?CompanyId=1002152

San Francisco Business Times: Tularik Inc related content

© 2008 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.

http://stlouis.bizjournals.com/sanfrancisco/related_content.html?topic=Tularik%20Inc

Anesiva, Inc. Announces Second Quarter 2006 Financial Results - News, Search Jobs, Events

SOUTH SAN FRANCISCO, Calif., Aug. 9 /PRNewswire-FirstCall/ -- Anesiva, Inc. today reported financial results for the second quarter and six months ended June 30, 2006.

http://www.biospace.com/news_story.aspx?StoryID=27064&full=1

Datamonitor - Anesiva, Inc. - Company Research, Analysis Reports, News, Profile

Anesiva is a biopharmaceutical company that develops and commercializes therapeutic treatments for pain management. It offers non-opioid analgesic products and powder intradermal injection systems.

http://www.datamonitor.com/companies/company/?pid=D9A37CE1-5FFC-4AFF-B923-A0C7BC067B0C